Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
There are data to suggest that some ductal carcinoma in situ (DCIS) may evolve through an evolutionary bottleneck, where minor clones susceptible to the imposed selective pressure drive disease progression. Here, we tested the hypothesis that an impact of the inflammatory environment on DCIS evoluti...
Main Authors: | Dominika Piasecka, Marcin Braun, Magdalena Mieszkowska, Lukasz Kowalczyk, Janusz Kopczynski, Radzislaw Kordek, Rafal Sadej, Hanna M. Romanska |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558620301494 |
Similar Items
-
Mucocele like Tumour of the Breast Associated with Ductal Carcinoma in situ and Focal Ductal Carcinoma: What is the Best Approach to these Patients?
by: Serdar Altinay, et al.
Published: (2016-09-01) -
Ductal carcinoma in situ (DCIS) in breast fibroadenoma
by: Manar El-Essawy, et al.
Published: (2020-05-01) -
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
by: Edward J. Jarman, et al.
Published: (2019-01-01) -
Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer
by: Sulma I. Mohammed, et al.
Published: (2020-02-01) -
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
by: Arantzazu Zubeldia-Plazaola, et al.
Published: (2018-07-01)